Concepedia

Nigel Parker

NP

Statistics

Publications

11

Citations

950

H-Index

11

Active since

2015

Affiliations

University of Eastern Finland(Current)

The University of Texas MD Anderson Cancer Center

FinVector (Finland)

Thomas Jefferson University

Johns Hopkins University

Nigel Parker is an author at University of Eastern Finland specializing in oncology, medicine, and bladder cancer.

Publications per year

2015–2024

11

Publications

11

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 442 citations · Full text

, , +13

Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study

Neal D. Shore, Stephen A. Boorjian, Daniel Canter et al. · Journal of Clinical Oncology · 2017 · 172 citations · Full text

, , +17

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar et al. · The Journal of Urology · 2024 · 75 citations · Full text

, , +9

Development of Large-Scale Downstream Processing for Lentiviral Vectors

Anniina J. Valkama, Igor Oruetxebarria, Eevi M. Lipponen et al. · Molecular Therapy — Methods & Clinical Development · 2020 · 68 citations · Full text

, , +17

Process Development of Adenoviral Vector Production in Fixed Bed Bioreactor: From Bench to Commercial Scale

Hanna P. Lesch, Kati Heikkilä, Eevi M. Lipponen et al. · Human Gene Therapy · 2015 · 44 citations

, , +13

1–5 of 11